- Home
- IBIO
IBIO
iBio Inc.
as 07-26-2024 4:00pm EST
iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: Biopharmaceuticals and Bioprocessing activities, conducted within iBio, Inc. and CDMO segment, conducted within iBio CDMO.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 18.5M | IPO Year: | N/A |
| Target Price: | $5.00 | AVG Volume (30 days): | 70.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.87 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.02 - $16.00 | Next Earning Date: | 05-13-2024 |
| Revenue: | $50,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest iBio Inc. News
IBIO Breaking Stock News: Dive into IBIO Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 months ago
iBio Closes Sale of Manufacturing Facility in Texas
GlobeNewswire
2 months ago
iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
4 months ago
iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases
GlobeNewswire
4 months ago
iBio Announces $15.0 Million Private Placement
Insider Monkey
4 months ago
12 Best Biotech Penny Stocks to Invest In
GlobeNewswire
5 months ago
iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka
GlobeNewswire
6 months ago
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."
Business Wire
6 months ago
Two New Knightscope Security Robots Now Protecting Houston Property
Compare IBIO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IBIO iBio Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.